thalidomide has been researched along with pyrimidinones in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corral, LG; Kaplan, G; Moreira, A; Muller, GW; Shire, MG; Stirling, DI; Wang, H | 1 |
| O'Connor, OA | 1 |
| Tobinai, K | 1 |
| Ogura, M | 1 |
| Chung, M; Doctor, ZM; Donovan, KA; Eleuteri, NA; Fischer, ES; Gray, NS; Li, Z; Mills, CE; Nowak, RP; Olson, CM; Pinch, BJ; Scott, DA; Sorger, PK | 1 |
2 review(s) available for thalidomide and pyrimidinones
| Article | Year |
|---|---|
Novel agents in development for peripheral T-cell lymphoma.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Depsipeptides; Drug Design; Drugs, Investigational; Histone Deacetylase Inhibitors; Humans; Immunologic Factors; Lenalidomide; Lymphoma, T-Cell, Peripheral; Purine Nucleosides; Pyrazines; Pyrimidinones; Salvage Therapy; Thalidomide | 2010 |
Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Drugs, Investigational; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Japan; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Multicenter Studies as Topic; Purine Nucleosides; Pyrimidinones; Thalidomide; Treatment Outcome | 2010 |
1 trial(s) available for thalidomide and pyrimidinones
| Article | Year |
|---|---|
[Current development of new drugs in malignant lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Brentuximab Vedotin; Diphtheria Toxin; Drug Discovery; Everolimus; Humans; Hydroxamic Acids; Immunoconjugates; Indoles; Inotuzumab Ozogamicin; Interleukin-2; Lenalidomide; Lymphoma; Lymphoma, B-Cell; Nitrogen Mustard Compounds; Purine Nucleosides; Pyrazines; Pyrimidinones; Recombinant Fusion Proteins; Sirolimus; Thalidomide; Vorinostat | 2012 |
2 other study(ies) available for thalidomide and pyrimidinones
| Article | Year |
|---|---|
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.
Topics: Humans; Kinetics; Lipopolysaccharides; Lymphocytes; Molecular Structure; Phthalimides; Pyrimidinones; Structure-Activity Relationship; Thalidomide; Tumor Necrosis Factor-alpha | 1996 |
Development and Characterization of a Wee1 Kinase Degrader.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; Drug Development; Female; Humans; Molecular Structure; Phthalazines; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteolysis; Pyrazoles; Pyrimidinones; Thalidomide | 2020 |